Document is current
Any future updates will be listed below
-
Authors
Lv, Jiawei
Wu, Chenfei
Li, Junyan
Chen, Foping
He, Shiwei
He, Qingmei
Zhou, Guanqun
Ma, Jun
Sun, Ying
Wei, Denghui
Lin, Li
-
Funding
Funding for this research was provided by:
National Innovation Talent Promotion Program (BX2021386)
- License Information
-
More Information
Article History
Received: 8 March 2022
Accepted: 4 July 2022
First Online: 23 August 2022
Declarations
:
: The study protocol was approved by the research and ethical committee of Sun Yat-sen University Cancer Center (SYSUCC). Experiments involving human participants were performed according to the recommendations of the research and ethical committee. A written informed consent was obtained from the patients. The REMARK guidelines (REporting recommendations for tumor MARKer prognostic studies) were followed.
: Not applicable.
: The authors declare that they have no competing interests.
